The Role of Short Chain Fatty Acids in Microbiota-gut-brain Axis — SCFA-AP  

Stress Clinical Trial

Official title: Effects of Short Chain Fatty Acids on Affective Processes in Humans

Status Completed

Clinical Trial Summary

The role of short chain fatty acids (SCFA) in the microbiota-gut-brain axis is examined in a sample of healthy volunteers. SCFA are the major products of bacterial fermentation of dietary fiber in the colon, and are hypothesised to mediate the bidrectional communication between the gut and the residing microbiota on the one hand, and the central nervous system on the other hand. We perform a 1-week intervention with SCFA and measure their effects on a range of affective outcomes in healthy male volunteers.

Clinical Trial Description

The study is an interventional double-blind, placebo-controlled, parallel group design with 3 arms (placebo, high-dose of SCFA, and low-dose of SCFA). The high and low doses of SCFA are equivalent to 20 and 10 grams of fiber respectively. Healthy male participants follow a low-fiber diet for the study duration (11 days). On day 4, baseline measurements are taken in the lab, including biological samples and psychophysiological measurements. Participants then consume placebo or SCFA for one week and revisit the lab on day 11 for a second measurement of the outcomes of interest. Specifically, we investigate the effect of SCFA supplementation on affective processing, including stress sensitivity, fear-related processes (e.g. extinction learning), and attentional bias to emotional stimuli. Volunteers also respond to questionnaires in relation to mood, and provide biological samples (blood and faecal samples) for analysis of circulating short chain fatty acids and microbiota composition, respectively. ;

Related Conditions & MeSH terms

• Emotions
• Fear
• Stress

• NCT number: NCT03688854
• Study type: Interventional
• Source: KU Leuven
• Status: Completed
• Phase: N/A
• Start date: January 4, 2018
• Completion date: September 15, 2018